January 05, 2021
The company is planning to produce 700 million doses per year. Around 200 million doses (per annum) will be produced in Hyderabad, 500 million doses in other cities
Bharat Biotech, which has been accorded Emergency Use Authorisation from
the drug regulator for its COVID-19 vaccine Covaxin, on Monday
said they are setting up four vaccine manufacturing facilities
with a combined capacity of 700 million doses per annum.
Denying allegations that the city-based vaccine maker lacks
data of Covaxin, Krishna Ella, chairman of Bharat Biotech,
said sufficient data has already been revealed and is available
on the net.